10 results about "Therapy related" patented technology

Systems, methods and devices are described for establishing trusted connections among two or more therapy devices that form, or form part of, a medication therapy system. A medication delivery electronics may include a first communication interface, a connection manager, and a therapy management application. A first communication interface may be configured to establish and communicate over one or more communication links. A connection manager may be configured to generate a candidate shared secret key and provide the shared key to a first therapy device over a first communication link established by a first communication interface. A candidate shared key may be generated responsive to one or more shared secret parameters. A therapy management application may be configured to receive, using the first communication interface, the first therapy related information from the first therapy device over a first trusted communication link established by the first communication interface responsive to acceptance of a candidate shared secret.

An improved machine learning based method for authorizing the performance of a treatment, comprising the steps of: receiving a treatment authorization request, the treatment authorization request including a historical record of the person who will receive the treatment and treatment identifying information relating to the treatment; creating an extracted text of the historical record using optical character recognition on the historical record; determining whether to analyze authorization performance of the treatment using a machine learning authorization process, wherein the determination is based on treatment identifying information and whether treatment authorization guidelines exist for the identified treatment; in response to a determination to analyze authorization performance of the treatment using a machine learning authorization process: identifying authorization criteria for the treatment based on the treatment authorization guidelines, wherein the authorization criteria includes records data conditional to authorization of performance of the treatment; identifying a natural language record processing model corresponding to the expense authorization guidelines; and performing natural language processing on the extracted text of the record in accordance with the identified natural language record processing model to identify relevant record data in the record; determining whether the relevant record data meets the authorization criteria and in response to a determination that the relevant record data meets the authorization criteria, authorizing the performance of the treatment.

Systems, methods and devices are described for establishing trusted connections among two or more therapy devices that form, or form part of, a medication therapy system. A, medication delivery electronics may include a first communication interface, a connection manager, and a therapy management application. A first communication interface may be configured to establish and communicate over one or more communication links. A connection manager may be configured to generate a candidate shared secret key and provide the shared key to a first therapy device over a first communication link established by a first communication interface. A candidate shared key may be generated responsive to one or more shared secret parameters. A therapy management application may be configured to receive, using the first communication interface, the first therapy related information from the first therapy device over a first trusted communication link established by the first communication interface responsive to acceptance of a candidate shared secret.

The invention provides a computer-implemented method (101, 301) for determining treatment data relating to treatment by means of a personal care device (1, 205). The method involves receiving (103, 303) first sensor data (SD1) generated by a first sensor (13, 215) and relating to a treatment parameter at a first moment of time (t1), and receiving (103, 303) second sensor data (SD2) generated by a second sensor (19, 229) and relating to a treatment condition of the personal care device with respect a body part subject of the treatment. If, based on the second sensor data, the personal care device is determined to be in an enabled treatment condition at said first moment of time wherein the treatment is enabled, the treatment data are determined (309) based on the first sensor data relating to the treatment parameter at said first moment of time. The method further involves, by comparing (105, 305) the second sensor data with first predetermined sensor data (PSD1), determining (105, 307) whether the second sensor is in a disabled condition at said first moment of time (t1). If the second sensor is determined to be in the disabled condition at said first moment of time, a predefined data usage rule is used to determine (109, 111, 113; 313) whether to base the treatment data on the first sensor data (SD1) relating to the treatment parameter at said first moment of time.

Methods and systems for providing therapy related data management are provided. The subject systems include one or more device components, and at least one memory storage unit and at least one data storage unit associated with such one or more device components. The device components may include one or more of an analyte monitoring system, a fluid delivery device and a remote terminal. The subject methods include use of the subject systems to optimize treatment of a patient.

Methods and systems for providing therapy related data management are provided. The subject systems include one or more device components, and at least one memory storage unit and at least one data storage unit associated with such one or more device components. The device components may include one or more of an analyte monitoring system, a fluid delivery device and a remote terminal. The subject methods include use of the subject systems to optimize. treatment of a patient.

The invention discloses a biomarker for predicting lung toxicity related to tumor immune checkpoint blocking treatment and application of the biomarker, and belongs to the technical field of medicine. The biomarker is a TNFSF8 gene or a TNFSF8 < + > CD4 < + > T cell, and analysis finds that the TNFSF8 gene or the TNFSF8 < + > CD4 < + > T cell is in significant positive correlation with the occurrence of immune checkpoint blocking treatment related lung toxicity. The invention also verifies the feasibility of the TNFSF8 + CD4 + T cell as the biomarker in peripheral blood and alveolar lavage fluid clinical samples for treating related pulmonary toxicity at immune checkpoints. The biomarker provided by the invention provides a scientific basis for early recognition of immune checkpoints to block treatment of related lung toxicity high-risk groups, reduces treatment risks for tumor patients and brings more clinical benefits, and has important clinical significance.

The present invention relates to an antibody specifically binding to human DR3 capable of specifically binding to a specific epitope of DR3 and selectively acting on regulatory T cells, thereby minimizing the activity of CD4 + T cells and CD8 + T cells exhibiting effector activity while strongly activating only the regulatory T cells, and a use thereof. The antibody has an excellent effect of preventing or treating graft versus host disease, autoimmune disease, and type 2 diabetes mellitus by induction of such selective activity on regulatory T cells, and thus can be usefully used as a therapeutic agent for various diseases related thereto.

The utility model discloses a portable injection device for gene therapy relates to medical instrument technical field, including the limiting sleeve, the top fixed mounting of limiting sleeve has the top cover, the bottom fixed mounting of top cover has the piston rod, the bottom fixed connection of piston rod has the rubber piston, the outside of rubber piston is equipped with the needle cylinder. The setting of portable injection device for gene therapy limiting sleeve can carry out effective protection to the piston rod and the reset spring in, and the top cover of limiting sleeve top can better with hand carry out the adhesion, to guarantee the comfort of use, the setting of telescopic positioning mechanism can make the cooperation needle cylinder telescopic in the inside of limiting sleeve, is favorable to automatic extraction to the liquid medicine when stretching out, and is favorable to reducing the length of whole when contracting, has improved portable injection device for gene therapy use convenience and storage convenience.

Systems and methods for remote therapy and patient monitoring are provided. A method comprises contacting an outer skin surface of a patient with a contact surface of a stimulator and transmitting an electrical impulse from the stimulator transcutaneously through the outer skin surface to a nerve within the patient. Data related to parameters of the electrical impulse applied to the nerve is stored and transmitted to a remote source. The data may include duration of treatment, amplitude of the electrical impulse, compliance with a prescribed therapy regimen or other relevant data related to the therapy. The method may further include collecting patient status data, such as symptoms of a medical condition (e.g., severity of a headache) before, during and / or after stimulation. The patient status data is correlated with the treatment data to monitor compliance and / or the effectiveness of the therapy.